Amelioration of popolysaccharide-induced sepsis in rats by free and esterified carnitine.

Autor: Gallo LL; Department of Biochemistry and Molecular Biology The George Washington University Medical Center 2300 Eye Street N.W. Washington, DC 20037 USA., Tian Y, Orfalian Z, Fiskum G
Jazyk: angličtina
Zdroj: Mediators of inflammation [Mediators Inflamm] 1993; Vol. 2 (7), pp. S51-6.
DOI: 10.1155/S0962935193000766
Abstrakt: The purpose of this study was to determine if free or esterified carnitine could alter fatty acid metabolism and ameliorate sepsis in lipopolysaccharide (LPS)-treated rats. Throughout a 96 h observation post-LPS, i.p. administration of both markedly reduced illness and accelerated recovery. Carnitine prevented the acute LPS-induced rise in serum triglycerides (45 +/- 6, 59 +/- 5 vs. 83 +/- 8 mg/ml, p < 0.001), respectively. This difference was accompanied by a significant increase in liver lipogenesis in LPS controls compared to both carnitines and normal rats (6.1 +/- 0.3 vs. 3.9 +/- 0.5, 4.3 +/- 0.5, and 1.8 +/- 0.4 mumol/h, respectively, p < 0.04). Compared to normal rats, total liver carnitine was significantly elevated in LPS controls and even higher in the carnitine groups (357 +/- 40 vs. 736 +/- 38, 796 +/- 79, and 1081 +/- 21 nmol/g). The data suggest that carnitines may be of therapeutic value in sepsis treatment and one action may be to partition fatty acids from esterification to oxidation.
Databáze: MEDLINE